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Abstract We report the successful expression of recombinant 
human ceruloplasmin which was made possible by inclusion of 
splicing signals in the expression vector. Ceruloplasmin cDNA 
expressed from the vector pNUT in baby hamster kidney cells 
gave protein yields of 0.03 mg/1 which increased to 15 mg/1 with 
splicing signals present. The defect in expression from the 
intronless cDNA is due to complete retention of ceruloplasmin 
mRNA in cell nuclei. The block to cytoplasmic export is 
alleviated by splicing signals, allowing full expression of the 
mRNA. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Ceruloplasmin (Cp) is the major copper binding protein of 
the serum and it has been suggested that one of its functions is 
to act as a ferroxidase, oxidising Fe2+ to Fe3+ for the efficient 
uptake of iron by transferrin [1]. Further support for the role 
of Cp in iron homeostasis is indicated in patients with heredi-
tary Cp deficiency who have high iron deposition in liver and 
brain [2,3]. Moreover the FET3 gene of yeast is required for 
high affinity transport of iron into yeast cells and has ferrox-
idase activity, with extensive sequence homology to multi-cop-
per oxidases, located on the cell surface [4,5]. The primary site 
of Cp synthesis is the liver where it is synthesised as an apo-
protein. Copper is then incorporated into the newly synthes-
ised Cp, prior to its secretion from the hepatocytes into sur-
rounding tissues [6]. This process is deficient in patients with 
Wilson's disease, who characteristically have an impaired abil-
ity to incorporate copper into their newly synthesised Cp, 
accompanied by a failure to excrete copper from the liver 
into the bile ; this results in the accumulation of toxic amounts 
of copper in the liver, kidney and brain [7]. Although the liver 
is the major site for Cp synthesis, Cp is expressed in other 
tissues, including the mammary gland [8], synovial tissues [9], 
and lung [10,11]. 
Studies on the biochemical properties and biological func-
tions of Cp have been hampered by its susceptibility to pro-
teolytic degradation during isolation. Uncertainty as to the 
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number and location of the copper atoms has recently been 
clarified by the solved X-ray structure of human serum Cp 
[12]. The structure reveals that Cp comprises six domains with 
three mononuclear sites, in domains 2, 4 and 6, and one 
trinuclear cluster at the interface of domains 1 and 6. With 
this new structural information on Cp, investigations into its 
role in both copper and iron metabolism can now be carried 
out using site-directed mutagenesis. However, successful ex-
pression of recombinant Cp is a prerequisite for such studies. 
Although human Cp was cloned in 1986 [13] there have 
been no reports of production of recombinant Cp. However, 
factor VIII, which shares structural homology with Cp [14], 
has been expressed in baby hamster kidney (BHK), as well as 
Chinese hamster ovary (CHO) cells [15]. We have therefore 
explored the possibility of using the BHK expression system 
for the production of human Cp as BHK cells have already 
been used successfully by us for the expression of recombinant 
wild-type and mutants of the amino-terminal lobe of human 
serum transferrin [16]. The BHK expression system for trans-
ferrins utilises the vector pNUT, in which the cDNAs are 
under the control of an inducible metallothionein promoter 
and polyadenylation signals are derived from the last exon of 
the gene for human growth hormone [17]. We now report the 
successful expression of recombinant Cp by modification of 
the pNUT vector to incorporate splicing signals from the 
second intron of rabbit ß-globin. This modification promotes 
cytoplasmic expression of Cp mRNA and stimulates protein 
production. 
2. Materials and methods 
2.1. Plasmid construction 
All plasmids were constructed by standard recombinant DNA tech-
niques [18]. The cDNA of human Cp (kindly provided by Professor 
J.D. Gitlin, Washington University School of Medicine, St. Louis, 
MO) was subcloned into pNUT to form pNUT-Cp. A 0.6 kb Nhel-
Hindlll fragment containing the second intron of the rabbit ß-globin 
gene was inserted upstream of the Cp cDNA to give pNUT-I-Cp. 
pcDNAA and pcDNA-ßGI are modified versions of pcDNAl (Invi-
trogen), in both of which the SV40 small-t intron has been excised out 
by digestion with Dral ; pcDNA-ßGI has had the ßGI inserted via the 
HindUl site on the vector. A 3.3 kb HindlU fragment containing the 
entire Cp cDNA was subcloned into the pcDNA vectors, downstream 
of the splicing signals in the case of pcDNA-ßGI-Cp. 
2.2. Cell culture and transfection 
BHK and COS cells were cultured in Dulbecco's modified Eagle's 
medium, supplemented with 10% foetal calf serum and antibiotics. 
Transient transfections were carried out using DEAE-dextran [19] 
for COS cells and using the LIPOFECTIN reagent (Gibco BRL) 
for BHK cells. Cells transfected with the pNUT constructs were in-
duced 24 h after transfection with 80 uM zinc sulphate [16]. 
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Fig. 1. Cellular localisation of Cp mRNA detected by ISA. Cp mRNA was expressed in BHK cells from (a) intronless pNUT-Cp, or (b) from 
vector with added splicing signals, pNUT-I-Cp. 
2.3. In situ hybridisation 
The intracellular distribution of Cp mRNA was monitored by ISH 
using riboprobes as described [20]. Cells grown on sterile coverslips 
were fixed 72 h after transfection in 2% paraformaldehyde (BDH 
Chemicals) for 15 min at room temperature. Cells were then dehy-
drated through a graded series (50, 70 and 95%) of ethanol solutions 
before hybridisation overnight with DIG-labelled antisense probes. 
Following treatment with RNase A and stringent washing to remove 
non-specifically bound probes, bound riboprobes were detected with 
an alkaline phosphatase-conjugated anti-DIG antibody (Boehringer-
Mannheim) and alkaline phosphatase activity was stained according 
to the manufacturer's instructions. 
2.4. RNA isolation and slot blot analysis 
Total RNA was isolated from cells 72 h after transfection by the 
acid guanidinium thiocyanate-phenol-chloroform method [21]. For 
hybridisation analysis of the RNA, 500 ng of total RNA was immo-
bilised on an N + Hybond nylon membrane (Amersham), using a slot 
blotting manifold. Each slot was further washed with 0.5 ml of 
ÎOXSSC. The membranes were baked at 80°C for 2 h and pre-hybri-
dised at 65°C for 1 h before probing overnight with a full-length, 
DIG-labelled antisense Cp riboprobe. Filters were washed stringently 
and bound probes were detected as above. After colour development, 
relative levels of Cp-specific RNAs were determined by scanning den-
sitometry, using an Oast Tech Gel Analysis System. These values were 
corrected for differences in RNA transfer efficiency by probing blots 
with riboprobes specific for ß-actin. 
2.5. Sandwich ELI S A 
A primary anti-human Cp antibody (Binding Site) was bound onto 
a multiwell plate, washed, then blocked overnight at 4°C. Cp from the 
expressed media was detected using a second anti-human Cp antibody 
labelled with horseradish peroxidase (HRP) (Binding Site) [22]. Col-
our was developed using o-phenylenediamine reagent (Sigma) and the 
absorbance read at 450 nm. The same principle for the quantitative 
determination of recombinant transferrin was used, a primary anti-
human transferrin antibody (Binding Site) was used and detection 
using a second anti-human transferrin antibody labelled with horse-
radish peroxidase (HRP) (Binding Site). 
2.6. Purification of Cp 
Recombinant Cp was partially purified from 200 ml of expressed 
medium from the BHK cells using a Sepharose-ethyleneimine column 
[23]. Purified human Cp was isolated from out-dated human plasma 
using affinity chromatography, on a Sepharose-ethyleneimine column, 
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Fig. 3. The level of Cp mRNA expressed from each construct. Total 
RNA from COS cells transfected with the indicated plasmid was 
measured by slot blot analysis. Both Cp (left) and ß-actin (right) 
mRNAs were assessed as described in Section 2. 
Fig. 2. Requirement of splicing signals for efficient cytoplasm ex-
pression of Cp mRNA. The intracellular distributions of Cp mRNA 
expressed from pNUT (D) or pNUT-I (■) in BHK cells were ana-
lysed semi-quantitatively. The localisation of Cp mRNA was cate-
gorised to reflect a movement from nucleus to cytoplasm. N, stain-
ing almost exclusively in the nucleus; Nc, more nuclear than 
cytoplasmic staining; nC, more cytoplasmic than nuclear staining; 
and C, staining almost exclusively in the cytoplasm. A minimum of 
100 cells have been scored for each transfection, for at least three 
transfections per plasmid, by three persons. The data has been nor-
malised and represented as percentage distributions between the 
four categories. 
mRNA into the cytoplasm (Fig. lb). The patterns of Cp 
mRNA distribution (Fig. 2) were evaluated semi-quantita-
tively [24] and the results substantiate the above finding that 
export of mRNA was enhanced when expressed from pNUT-
I-Cp. 
When the experiments were repeated with pcDNA-ßGI-Cp 
and pcDNAA-Cp in COS cells, we found that once again 
most of the Cp mRNA expressed from the intronless vector 
pcDNAA was retained inside the nucleus, while 99% of the 
signal from pcDNA-ßGI-Cp was mainly or exclusively in the 
cytoplasm (data not shown). 
and ion-exchange chromatography on a Mono Q column (Pharma-
cia). 
2.7. Western blotting 
Detection of Cp was carried out by resolving samples on 10% SDS-
PAGE, transferring proteins electrophoretically to nitrocellulose 
membrane, blocking with 3% BSA in PBS containing 0.01% Tween 
20 and incubated with anti-human Cp antibody labelled with HRP. 
The blot was washed three times with PBS containing 0.05% Tween 
20 and the resulting immune complexes detected with the diamino-
benzidine reagent (Sigma). 
3. Results 
3.1. Assessment of intracellular distribution of Cp mRNA by 
ISH 
Using ISH to detect the presence and localisation of Cp 
mRNA, it was found that Cp mRNA expressed from 
pNUT-Cp was completely retained in the nuclei of BHK cells 
(Fig. la). In contrast, inclusion of splicing signals in the ex-
pression vector (pNUT-I-Cp), allowed efficient export of Cp 
3.2. Quantification of Cp mRNA by slot blot analysis 
Total Cp mRNA levels were measured by slot blot analysis 
(Fig. 3). It was found that the total amount of Cp mRNA 
produced from each pair of vectors was fairly similar, irre-
spective of the presence of splicing signals (Table 1). 
3.3. Quantification and characterisation of Cp by an ELIS A 
and Western blotting 
The amounts of Cp protein expressed from BHK and COS 
cells was quantified by an ELISA and are shown in Table 1. 
BHK cells transfected with pNUT-I-Cp produced 15 mg/1 of 
protein, a 500-fold increase compared with cells transfected 
with pNUT-Cp. COS cells produced similar amounts of pro-
tein from pNUT-I-Cp, 16-31 mg/1, but levels expressed from 
pNUT-Cp were below the limits of detection of the ELISA. 
Western blotting showed that the partially purified recombi-
nant Cp expressed in BHK cells had a major band at 132 kDa 
corresponding to intact human Cp (Lane 2, Fig. 4). This 
compared with the pattern obtained in a crude human serum 
Table 1 
The distribution and expression levels of Cp mRNA and protein in BHK/COS cells transfected with different constructs 
Construct Cell line mRNA localisation8 Relative levels of Cp mRNAb Protein levels (mg/l)c 
pNUT-Cp 
pNUT-I-Cp 
pcDNAA-Cp 
pcDNA-ßGI-Cp 
pNUT-Tf 
BHK 
COS 
BHK 
COS 
COS 
COS 
BHK 
N 
N 
C 
C 
Nc 
C 
C 
1.0 
1.0 
1.1 
1.4 
0.03 
N.D.d 
15 
16-31 
N.D.d 
100 
7 
"Intracellular localisation of Cp mRNA categorised as described in the legend to Fig. 2. 
bThe relative efficiency of Cp mRNA production by different constructs was determined by taking the value obtained from pNUT-Cp as a reference 
point and the values from other constructs are expressed as a ratio of the intensities to that of pNUT-Cp; values are normalised to the signal from 
ß-actin. 
cProtein levels were assayed by an ELISA, which has been performed in duplicates, repeated at least twice. 
dNot detectable. 
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Fig. 4. Western blot analysis of Cp. Lane 1, MW markers; Lane 2, partially purified recombinant Cp; Lane 3, normal serum sample; Lane 4, 
purified serum Cp. The arrow shows the location of the 132 kDa band of ceruloplasmin. 
sample (Lane 3, Fig. 4). Human Cp purified from out-dated 
human plasma contained very low levels of full-length protein 
(Lane 4, Fig. 4). 
4. Discussion 
Although we have obtained only very low levels of Cp 
production in cells transfected with pNUT-Cp we have dem-
onstrated, using ISH, that this is due to retention of Cp 
mRNA in the nucleus. Export of Cp mRNA into the cyto-
plasm, which is accompanied by enhanced levels of protein 
expression, can be achieved by inclusion of splicing signals in 
the expression vector. However, as the levels of mRNA pro-
duced from vectors with and without splicing signals are sim-
ilar, the enhanced expression of Cp protein cannot be attrib-
uted to any significant extent by the effects of the intron on 
transcription [25,26]. Nor does it seem likely that the lack of 
cytoplasmic mRNA expressed from the intronless constructs 
is due to a very rapid turnover of cytoplasmic RNA - the 
mRNAs expressed from the vectors with the ßGI are almost 
identical in sequence to those expressed from the intronless 
counterparts, except for the inclusion of 53 bp of spliced ß-
globin mRNA upstream of the Cp reading frame. ß-Globin 
has been used in studies of mRNA turnover and is relatively 
stable, but can be induced to turn over rapidly if part of a 
chimeric transcript containing destabilising signals from an-
other gene [27,28], indicating that ß-globin mRNA does not 
possess the ability to stabilise otherwise rapidly turned over 
mRNA. Instead, the effect of splicing signals in the vectors 
seems to be at the level of nucleocytoplasmic export of 
mRNA into the cytoplasm. The same patterns of mRNA 
distributions from experiments performed in two different sys-
tems, pNUT/BHK and pcDNA/COS (Table 1), demonstrate 
that the nuclear retention of unspliceable mRNA, and the 
enhancement of nucleocytoplasmic export by splicing signals, 
are not an artefact of the plasmid or the cell line used. In the 
case of Cp there seems to be an absolute requirement of 
splicing signals for cytoplasmic expression of mRNA. Other 
studies have documented enhanced efficiency of expression of 
cytoplasmic mRNA by the inclusion of splicing signals [29-32] 
and the requirement seems to be general for most cDNAs 
derived from genes containing introns. What is striking in 
the case of Cp is that so little protein is expressed without 
the splicing signals which contrasts strongly with human 
transferrin where significant amounts of protein are expressed 
from the intronless form of pNUT (Table 1). Interestingly, 
ISH reveals that transferrin mRNA can be exported to a 
significant degree to the cytoplasm of BHK cells without the 
need for splicing. In addition, amongst a survey of mRNAs 
expressed from cDNAs of genes which normally contain in-
trons varying degrees of cytoplasmic expression were observed 
(Fu, Suen, Waseem and White, unpublished results), but 
uniquely Cp mRNA was exclusively retained in the nucleus. 
The complete lack of nucleocytoplasmic export of Cp mRNA 
in the absence of splicing signals is suggestive of a specific 
retention of the RNA in the nucleus. Such a mechanism has 
been demonstrated for the aberrant nuclear localisation of a 
tRNA harbouring a single point mutation [33]. Further work 
is required to characterise the putative retention sequence of 
Cp mRNA and determine whether or not such retention plays 
a role in the regulation of expression of the Cp gene. 
It is well known that human Cp is susceptible to proteolytic 
attack during its isolation from serum and this has been the 
major obstacle in the study of the physicochemical character-
istics of the protein. However, the recombinant Cp expressed 
in BHK cells appears to be intact, as very little degradation 
was observed upon analysis by SDS-PAGE. Work is now in 
progress to assess the physicochemical properties of the re-
combinant protein ahead of the use of site-directed mutagen-
esis to explore structure-function relationships in Cp. 
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